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Decades of poor medical and veterinary antibiotic prescribing 
and a lack of regard for the practice of infection prevention and 
control (IPC) in our hospitals have left South Africa, like the rest 
of the international community, on the brink of a return to an era 
of untreatable bacterial infection. The recent emergence in South 
Africa of bacteria carrying the highly mobile New Delhi metallo-β-
lactamase-1 (NDM-1) gene,1 which has been associated with rapid 
spread of carbapenem-resistant Enterobacteriaceae (CRE), and, 
for the first time in Africa, Klebsiella pneumoniae carbapenemases 
(KPCs),2 will have a profound effect on the lives of our patients and 
on the health service. The acquisition of drug-resistant hospital-
acquired infections (HAIs) increases morbidity, mortality and the 
cost of patient management to an already beleaguered health system 
by increasing the duration of hospital stay, often in expensive 
intensive care units (ICUs), and antibiotic prescribing costs.3,4 
Unlike the case of multidrug-resistant (MDR) and extensively 
drug-resistant tuberculosis, the situation we find ourselves in with 
MDR Gram-negative bacteria such as CRE cannot be blamed on poor 
patient compliance, or merely on the introduction of resistant strains 
from foreign climes. Rather, this is a home-grown problem, generated 
and perpetuated by doctors, nurses and allied healthcare workers in 
South Africa. 
For resistant Gram-positive bacteria, there often remain more 
expensive antibiotic options. Vancomycin or teicoplanin are available 
to treat methicillin-resistant Staphylococcus aureus (MRSA), while 
linezolid or daptomycin may be used for MRSA as well as vancomycin-
intermediate S. aureus and vancomycin-resistant S. aureus. However, 
the situation for managing CRE is far more serious. We have become 
reliant on colistin, a nephrotoxic polymixin antibiotic developed in 
the 1960s. Reports of colistin-resistant Pseudomonas aeruginosa, K. 
pneumoniae and Acinetobacter baumannii rendering the bacteria 
pan-drug resistant are already documented.5-7 Most worrying of all is 
the total lack of new antibiotics against Gram-negative infections in 
the antibiotic pipeline for the next 10 - 20 years. 
In this issue of the journal, Brink et al.8 set out the risk factors 
for acquisition of CRE and some of the issues around prevention 
and management. But how are we to respond to the wider issues of 
antibiotic stewardship in South Africa at this late stage, even though 
the ‘horse has bolted’? The approach must be multifaceted. Simply 
put, we must force a return to rational antibiotic prescribing through 
strong antibiotic stewardship, with equal emphasis on addressing IPC 
to prevent spread of already resistant bacteria between patients. 
IPC in South Africa lurches from crisis to crisis without getting to 
the core of the problem, that of collective responsibility. IPC is often 
viewed as the domain of a select few practitioners, mostly nurses, 
supported by microbiologists or infectious disease specialists, who 
are meant to police our hospitals and ensure that our patients and 
staff protect themselves and others from spreading and contracting 
communicable diseases. However, if we are to confront the crisis 
we find ourselves in and prevail, the first change required is in our 
mindset. IPC is not the domain of the few, but the responsibility of all. 
We must move towards a situation where all healthcare providers in 
this country become advocates for infection prevention and control, 
and practise what they preach. Trained IPC officers certainly have 
a role to play in governance of IPC, and government must meet its 
obligations to fund posts for IPC officers to meet standard norms. 
However, no number of IPC officers in a hospital can prevent the 
spread of MDR bacteria, if healthcare workers fail to disinfect their 
hands between patients. And here lies the one real hope for the 
future in terms of IPC. The changes that need to be put in place 
are simple. They do not require complex systems or costly financial 
interventions. There are few unknowns in the field, and research 
and clinical findings from other countries are equally relevant in 
our setting. Each healthcare institution in this country must have 
administrative and environmental policies in place to enable them to 
correctly identify and isolate patients with MDR bacterial infections 
and must provide running water, soap and hand disinfectants as well 
as the personal protective equipment required to ensure standard 
precautions against spread. The adoption of evidence-based, simple 
bundles of care designed by the Best Care … Always! campaign9,10 
simplifies the practice of IPC in the ICU and ward setting, and their 
adoption nationally would be another milestone for change. 
Unlike IPC, the drivers for change in antibiotic prescribing 
are less simple. Rational antibiotic prescribing requires a basic 
knowledge of the mechanism of action of antibiotics, the leading 
causes of a particular infection, and the resistance patterns of 
bacteria in the local healthcare setting. Outside of central and private 
hospitals, surveillance of antibiotic resistance is rarely practised, 
hampering rational prescribing. Antibiotic stewardship refers to a 
multifaceted approach that healthcare organisations undertake to 
optimise prescribing, including policies, guidelines, surveillance, 
education and audit.11 In some private and public hospitals, antibiotic 
stewardship programmes (ASPs) are under way or being developed. 
To help co-ordinate these efforts across the healthcare sector, the 
Federation of Infectious Diseases Societies of Southern Africa 
(FIDSSA), which represents adult and paediatric infectious disease 
physicians, clinical microbiologists, and infection control, travel 
medicine and sexually transmitted diseases practitioners in southern 
Africa, arranged the first South African Antibiotic Stewardship 
Programme (SAASP) conference in February 2012. A working group 
developed an ASP for South Africa, the goals of which are to:
•	 Provide leadership, advocacy for and strengthening of antibiotic 
stewardship in the public and private sectors in South Africa
•	 Direct appropriate training in antibiotic stewardship and 
co-ordinate dissemination of antibiotic stewardship information 
to all sectors of South Africa’s healthcare system and civil society
•	 Harmonise and unify existing national antibiotic prescribing 
guidelines and develop guidelines for those infections not already 
covered, for adult and paediatric practice, incorporating principles 
of antibiotic stewardship and optimal diagnostic testing
•	 Identify gaps in current knowledge and the necessary operational 
research/audit that will inform practice, and feed back the results 
of these studies to stakeholders, so as to implement change
•	 Engage with the National Department of Health and industry to 
address the economic issues and systemic obstacles surrounding 
antibiotic costs and stewardship.
As is the case for promotion of IPC, a move towards rational 
antibiotic prescribing must be embraced by all prescribers in South 
Africa and requires a commitment to education. The rise of CRE did 
not occur as a result of the injudicious use of carbapenems alone, 
but due to misuse and overuse of all antibiotics. We need to reduce 
the overall consumption of antibiotics, and to limit the duration 
of therapy in accordance with evidence-based guidelines when 
available, or expert opinion when not. We need to know what we are 
treating and to be able to de-escalate from broad-spectrum empiric 
therapy to targeted narrow-spectrum antibiotics that are less likely 
to lead to resistance. Taking appropriate cultures from sterile sites 
is therefore a key component of rational prescribing and a practice 
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that is sorely lacking at all levels of healthcare in South Africa. Daily 
review of the route of administration of antibiotics is another key 
component, allowing a reduction in intravenous therapy and removal 
of indwelling intravascular catheters, thereby reducing the risk of 
catheter-associated bloodstream infections. 
The horse has indeed bolted, but it is not too late to limit the 
emergence and spread of MDR bacterial infection in South Africa. 
To achieve this goal, there must be a sea-change in practice and a 
means to control poor prescribing practice should it continue in our 
hospitals. 
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